ALZHEIMER'S TREATMENTS:
What Helps, What to Know, and How to Decide
If you or someone you care for is living with cognitive decline, it can be difficult to make sense of Alzheimerās treatments, medications, and the many lifestyle recommendations you may encounter.
Ā
This page is designed to help you understand what current treatments can and canāt do, how they fit into the bigger picture of brain and metabolic health, and how a pharmacist-led, whole-person approach can support thoughtful, informed decisions.
Quick Navigation Index
Current Alzheimerās treatments focus primarily on:
- Managing symptoms
- Slowing progression in select individuals
- Supporting safety and daily function
Ā
They do not fully reverse the disease, and they work differently for each person. This is why treatment decisions benefit from careful consideration of medical history, medications, lifestyle factors, and personal goals.Ā
Cognitive decline rarely occurs in isolation.
Ā
Brain health is closely connected to:
- Metabolic health and blood sugar balance
- Sleep, stress, and inflammation
- Nutrition and physical activity
- Medication effects and interactions
Ā
Understanding how these factors interact can make treatment decisions clearer and more personalized.
Cholinesterase Inhibitors
(Donepezil, Rivastigmine, Galantamine)
- Most helpful in early to moderate stages
- May improve attention, memory, and daily function
- Common side effects: nausea, appetite changes, sleep issues
Ā
Memantine
- Often used in moderate to later stages
- Helps regulate glutamate signaling in the brain
- Can support behavior and daily activities
Ā
Explore the evidence behind these medications, including how they work,Ā who may benefit, common side effects, and questions to ask your provider:Ā
Ā
Anti-Amyloid Monoclonal Antibodies
(e.g., lecanemab, donanemab)
Ā
These therapies:
- Target amyloid plaques in the brain
- Are intended for early Alzheimerās or MCI due to Alzheimerās
- Require MRI monitoring
- Carry risks such as brain swelling or microbleeds (ARIA)
Ā
Important considerations before starting:
- Eligibility criteria
- MRI access and monitoring schedule
- Cost and insurance coverage
- Individual risk tolerance and goals of care
Ā
Look at what the data actually shows, including potential benefits and risks, for:Ā
Ā
Medications work best when paired with supportive strategies:
Ā
Nutrition: Mediterranean-style eating patterns
Movement: Regular aerobic and strength-based activity
Sleep optimization
Cognitive engagement
Caregiver education and stress reduction
Ā
These approaches can:
- Improve daily functioning
- Reduce behavioral symptoms
- Support overall brain resilience
Ā
Dive deeper into science-supported habits that boost brain health and quality of life, comparing:Ā
Ā
These medications do not slow Alzheimerās disease progression, but may help manage agitation or sleep disruption when symptoms affect safety or quality of life.
Brexpiprazole (RexultiĀ®) is FDA-approved to treat agitation associated with dementia due to Alzheimerās disease, including restlessness, irritability, or aggressive behaviors.
Ā
It works by modulating dopamine and serotonin activity in the brain. This medication is typically considered when non-drug strategies are not enough and requires careful monitoring due to known safety risks in older adults.
Suvorexant (BelsomraĀ®) is used to treat difficulty falling or staying asleep, a common challenge in Alzheimerās disease.
Ā
Unlike traditional sedatives, it works by blocking orexin, a wake-promoting brain chemical. Studies including people with Alzheimerās show improved total sleep time, which may support daytime function and caregiver well-being.
Medications for agitation or sleep are supportive tools, not first-line Alzheimerās treatments.Ā They are most appropriate when symptoms interfere with safety, daily care, or caregiver strain.Ā
Ā
A pharmacist-guided review can help determine whether benefits outweigh risks and how these options fit alongside cognitive medications and lifestyle strategies.
Alzheimerās treatment costs vary widely depending on therapy type, disease stage, and insurance coverage.
Ā
Traditional medications are often low-cost generics and may be covered by insurance.Ā
Ā
Newer biologic therapies can involve high annual costs, along with required imaging and infusion services.Ā
Ā
Coverage varies by diagnosis, stage, and payer.
Some individuals and caregivers also choose self-pay support for added guidance, such as:
Ā
- Independent pharmacist medication reviews
- Health coaching and whole-person education
Ā
The goal is clearer decisions ā not more complexity.
To bring clarity to complex decisions, I use a structured framework called the Functional Medicine (FM) Operating System.
Ā
Rather than focusing on isolated symptoms, this holistic approach weaves together treatments, metabolism, lifestyle, and your story into a personalized plan.
Ā
The FM Tree is a visual model that helps explain how symptoms such as memory changes, fatigue, or weight gain may stem from shared underlying contributors. It encourages us to look beyond symptoms alone and consider factors like blood sugar balance, inflammation, sleep, stress, medications, and nutritionāall of which influence brain function and metabolism. For caregivers, this approach shifts the focus from āwhatās failingā to āwhatās influencing,ā supporting more compassionate, informed care decisions.
Ā
The FM Timeline is a structured way to map your health history across your life to uncover patterns that may still be affecting you today. Because cognitive and metabolic changes often develop gradually, it helps identify when contributors like prolonged stress, medication use, or hormonal shifts beganāallowing for more accurate support. For caregivers, this fuller picture reduces confusion, validates lived experience, and builds confidence in next steps.
Ā
Curious if this approach is right for you?Ā
Ā
Ā
The FM Matrix is a clear snapshot of how key body systemsābrain, metabolism, digestion, hormones, and immune functionāare working together right now. It helps caregivers see how daily habits and supports affect symptoms, making care decisions feel more understandable and less overwhelming. By highlighting which actions have the greatest impact, the Matrix allows caregivers to focus on what matters most, track progress across systems, and support more sustainable changes that promote cognitive resilience and metabolic stability over time.
Ā
Ā
š Get guidance from a pharmacist who understands caregiving ā Caregiver Pharmacist Consultation
In early stages, some medications may lead to subtle improvements in attention, focus, or daily functioning within weeks to a few months. Other treatments aim primarily to slow progression, which may not feel immediately noticeable.
Ā
Lifestyle strategies ā such as improving nutrition, sleep, physical activity, and stress management ā may support energy, mood, or daily routines within weeks, while brain-related benefits tend to build over several months. The greatest benefit is often seen when medication care and lifestyle changes are combined early.
Ā
š Schedule a Personalized Alzheimerās Medication Review
In later stages, treatments are less likely to improve memory but may help support behavior, comfort, and daily function. Benefits may include reduced agitation, improved routines, or better tolerance of daily care.
Ā
Lifestyle and environmental strategies can still be meaningful, particularly for:
Ā
- Comfort and safety
- Sleepāwake patterns
- Reducing distress for both the individual and caregiver
Ā
In later stages, success is often measured by quality of life rather than cognitive improvement.
Ā
š Schedule a Personalized Alzheimerās Medication Review
No. Response varies widely based on:
Ā
- Stage of disease
Ā
- Overall health and metabolic factors
Ā
- Genetics
Ā
- Medication tolerance and interactions
Ā
- Consistency with supportive lifestyle habits
Ā
Ā
This variability is why treatment plans benefit from ongoing review and individualization rather than a one-size-fits-all approach.
Ā
Ā
šĀ Schedule a Personalized Alzheimerās Medication Review
Yes. Alzheimerās care is dynamic. Medications, doses, and lifestyle strategies may be adjusted as symptoms, goals, or side effects change.
Ā
Regular reassessment helps ensure that treatment continues to offer benefit without unnecessary burden ā especially as care priorities evolve over time.
Ā
Ā
š Schedule a Personalized Alzheimerās Medication Review
Yes. Evidence supports combining medication management with evidence-based lifestyle and supportive strategies at all stages of Alzheimerās.Ā
Ā
While lifestyle changes are not a cure, they may help:
Ā
- Support daily function and routines
- Reduce symptom burden
- Improve resilience and caregiver well-being
Ā
Medication and lifestyle strategies are complementary, not competing ā and together often provide the most practical benefit.
Ā
š Schedule a Personalized Alzheimerās Medication Review
If youād like personalized guidance for your unique situation, schedule a one-on-one consultation.
Ā
Together, we can:
- Clarify your treatment options
- Assess medication risks and interactions
- Review coverage and cost considerations
- Prevent unnecessary or duplicative therapies
- Support informed, values-aligned decisions
- Collaborate with your existing medical team
Ā
The goal is simple: not more care ā but better conversations, prioritization, and follow-through.
References
Alzheimer's Association & Centers for Disease Control and Prevention. (2023). Healthy Brain Initiative: State and local road map for public health, 2023ā2027. Centers for Disease Control and Prevention. https://www.cdc.gov/aging/healthybrain/roadmap.htm
Ā
Bland, J. S. (2015).Ā Functional medicine: An operating system for integrative medicine.Ā Integrative Medicine: A Clinician's Journal,Ā 14(5), 18ā20.Ā https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712869/
Ā
Jaqua, E. E., Tran, M. N., & Hanna, M. (2024). Alzheimer disease: Treatment of cognitive and functional symptoms.Ā American Family Physician,Ā 110(3), 281-293.
Ā
National Institute on Aging. (2024, July). Alzheimer's disease fact sheet (NIH Publication No. 24-AG-6423). U.S. Department of Health and Human Services, National Institutes of Health. https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet
Ā
Reuben, D. B., Kremen, S., & Maust, D. T. (2024). Dementia prevention and treatment: A narrative review.Ā JAMA Internal Medicine,Ā 184(5), 563-572.Ā https://doi.org/10.1001/jamainternmed.2023.8522
Functional Pharmacy
BODY, MIND, AND SOUL
Vestal,Ā New YorkĀ 13850
Join the List for Exclusive Event Invites
Your privacy is respected. Your email is never shared. Unsubscribe anytime.
The content on this website is for educational purposes only and is not a substitute for professional medical advice.Ā Always consult your healthcare provider before making health decisions.
2026 Functional Pharmacy LLC. All rights reserved. Artwork by Pasha.